Excel Industries Q4 FY26 Earnings Call Transcript Released
Excel Industries released its Q4 & FY26 earnings call transcript. The company reported FY26 net revenues of ₹1,094 crores, up 11.8%, and PAT of ₹73 crores. A final dividend of ₹13.75 per share was declared. Capex of ₹200-300 crores is planned over 2-3 years for growth areas. Management aims to increase exports and contract manufacturing.
The transcript provides detailed financial performance for Q4 and FY26, outlines future growth strategies, capex plans, and dividend declaration. This information is material for investors assessing the company's outlook and financial health, impacting investment decisions.
The sentiment is neutral as the announcement is a factual transcript of an earnings call. While it discusses business performance and future plans, it also includes investor concerns about stagnation and management's responses, balancing positive and cautious elements.
Excel Industries Limited has released the transcript of its earnings call for the fourth quarter and full financial year 2026, which concluded on March 31, 2026. The call, held on May 25, 2026, featured insights from Managing Director Mr. Ravi Shroff, President and COO Mr. Pradeep Ghattu, and CFO Mr. Devendra Dosi.
During the call, management discussed the performance of FY26, noting that the first half was challenging due to an extended monsoon impacting the agrochemical sector. However, demand improved in Q4 FY26, partly compensated by strong performance in Yellow Phosphorus (YP) derivatives and Performance Solutions. The company highlighted operationalization of a 2,530 tons per annum capacity addition for biocides in the second half of FY26 and progress on a long-term contract manufacturing agreement with a multinational company, with capacity expected by July 2026.
Financially, standalone quarterly revenues for Q4 FY26 were ₹281 crores, a 13% year-on-year increase, with Adjusted EBITDA at ₹22 crores. For the full year FY26, net operating revenues were ₹1,094 crores (up 11.8% from FY25), and profit after tax was ₹73 crores. The company maintains a strong balance sheet with zero long-term debt and a net cash position.
Management addressed investor concerns about stagnation, emphasizing the cyclical nature of the chemical business and highlighting long-term growth strategies. Capex plans of ₹200-300 crores over the next two to three years are focused on Performance Solutions, contract manufacturing, and YP derivatives, with expected fixed asset turnover of 1-1.5 times and ROI of 15-20%.
The company also announced a final dividend of ₹13.75 per equity share (275% of face value). Future growth drivers for FY27 are expected to be Performance Solutions, YP Derivatives, and Contract Manufacturing. Management aims to increase export share and expand its presence in the EU and US markets, leveraging the China plus one strategy and evolving trade dynamics.
What to do with a filing like this
Excel Industries Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Excel Industries Limited. Read the original for the full detail.